TEK

TEK, also known as angiopoietin - 1 receptor, is commonly referred to as Tie - 2. This protein plays a crucial role in angiogenesis, the process of forming new blood vessels. It functions mainly through binding to angiopoietin ligands, which regulate vascular stability and endothelial cell survival. The TEK - related signaling pathway involves the PI3K - AKT and MAPK pathways.
Dysregulation of TEK is linked to various diseases such as cancer, where it promotes tumor angiogenesis, and vascular malformations. In terms of drug development, several anti - angiogenic agents targeting the TEK pathway are in pre - clinical and clinical trials, aiming to inhibit abnormal blood vessel growth and improve disease prognosis.